Personalis to Present at Upcoming Investor Conferences

Rhea-AI Summary

Personalis, Inc. (Nasdaq: PSNL) has announced participation in two upcoming investor conferences. The management team will present at the Cowen 41st Annual Healthcare Conference on March 2, 2021, at 1:30 p.m. ET, and at the Barclays Global Healthcare Conference on March 10, 2021, at 11:30 a.m. ET. Personalis specializes in advanced genomics for cancer, operating one of the largest sequencing programs and providing critical molecular data through its ImmunoID NeXT Platform.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will present at the following upcoming investor conferences:

• Cowen 41^st Annual Healthcare Conference
  Presenting on Tuesday, March 2, 2021 at 1:30 p.m. Eastern Time

• Barclays Global Healthcare Conference
  Presenting on Wednesday, March 10, 2021 at 11:30 a.m. Eastern Time

About Personalis, Inc.

Personalis, Inc. is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing programs globally and is currently the sole sequencing provider to the U.S. Department of Veterans Affairs Million Veterans Program. In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis^® ImmunoID NeXT Platform^® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue or blood sample. The Personalis^® Clinical Laboratory is GxP aligned as well as CLIA’88-certified and CAP-accredited.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210216005089/en/

FAQ

When is Personalis, Inc. presenting at the Cowen 41st Annual Healthcare Conference?

Personalis, Inc. will present on March 2, 2021, at 1:30 p.m. Eastern Time.

What time is Personalis, Inc.'s presentation at the Barclays Global Healthcare Conference?

The presentation at the Barclays Global Healthcare Conference is scheduled for March 10, 2021, at 11:30 a.m. Eastern Time.

What is the focus of Personalis, Inc.'s business?

Personalis, Inc. specializes in advanced genomics for cancer, offering comprehensive molecular data through their ImmunoID NeXT Platform.

What does the ImmunoID NeXT Platform provide?

The ImmunoID NeXT Platform provides biopharmaceutical customers with information on approximately 20,000 human genes and immune response from a single tissue or blood sample.

What certifications does Personalis, Inc.'s Clinical Laboratory hold?

Personalis, Inc.'s Clinical Laboratory is GxP aligned, CLIA’88-certified, and CAP-accredited.